Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)

Market Cap	142.73B
Revenue (ttm)	17.95B
Net Income (ttm)	1.02B
Shares Out	316.16M
EPS (ttm)	3.28
PE Ratio	137.66
Forward PE	98.92
Dividend	n/a
Ex-Dividend Date	n/a

Volume	172,266
Average Volume	229,191
Open	457.05
Previous Close	451.45
Day's Range	453.30 - 472.15
52-Week Range	327.40 - 493.35
Beta	n/a
RSI	64.39
Earnings Date	Aug 8, 2025

About Dr. Agarwal's Health Care

Dr. Agarwal's Health Care Limited operates eye hospitals in India and internationally. It offers cataract surgeries, such as small incision cataract surgery, phacoemulsification, robotic cataract surgery, and glued intraocular lens treatments; and refractive surgeries, including surgical procedures to correct the refractive error of the eye to get rid of or reduce dependence on glasses and contact lens. The company also provides surgical retinal treatments, corneal transplantation and pinhole pupilloplasty, oculoplasty, and surgeries for the tr...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 4,214
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: AGARWALEYE

Financial Performance

In 2024, Dr. Agarwal's Health Care's revenue was 17.11 billion, an increase of 28.44% compared to the previous year's 13.32 billion. Earnings were 834.60 million, an increase of 0.48%.